Epidermal growth factor receptor mutations

Details for Australian Patent Application No. 2006216477 (hide)

Owner Amgen Inc.

Inventors Juan, Todd; Radinsky, Robert; Freeman, Daniel

Agent Wrays

Pub. Number AU-A-2006216477

PCT Pub. Number WO2006/091899

Priority 60/656,263 24.02.05 US

Filing date 23 February 2006

Wipo publication date 31 August 2006

International Classifications

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/091899 Priority application(s): WO2006/091899

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216493-Immunostimulatory oligonucleotides

2006216473-Method for the treatment of retinopathy of prematurity and related retinopathic diseases